✦ LIBER ✦

Adalimumab in steroid-dependent Crohn's disease patients: Prognostic factors for clinical benefit

✍ Scribed by Ambrogio Orlando; Sara Renna; Filippo Mocciaro; Maria Cappello; Roberto Di Mitri; Claudia Randazzo; Mario Cottone

Book ID: 112101173
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 732 KB
Volume: 18
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.21835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab in Steroid-Dependent Crohn's

Adalimumab in Steroid-Dependent Crohn's Disease Patients: Analisys of Efficacy, Prognostic Factors for Clinical Benefit and Safety

✍ Orlando, Ambrogio ;Renna, Sara ;Mocciaro, Filippo ;Cappello, Maria ;Di Mitri, Ro 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 68 KB

OC.07.6: ADALIMUMAB IN STEROID-DEPENDENT

OC.07.6: ADALIMUMAB IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS: ANALISYS OF EFFICACY, PROGNOSTIC FACTORS FOR CLINICAL BENEFIT AND SAFETY

✍ A. Orlando; S. Renna; F. Mocciaro; M. Cappello; R. Di Mitri; C. Randazzo; M. Cot 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Adalimumab in a patient with steroid-dep

Adalimumab in a patient with steroid-dependent Crohn's disease

✍ Rosy Tambasco; Fernando Rizzello; Paolo Gionchetti; Massimo Campieri 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 310 KB

P.06.19 LONG TERM ADALIMUMAB EFFICACY IN

P.06.19 LONG TERM ADALIMUMAB EFFICACY IN STEROID-DEPENDENT CROHN'S DISEASE PATIENTS

✍ Orlando, A.; Renna, S.; Mocciaro, F.; Cappello, M.; Bravatà, I.; Di Mitri, R.; C 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 686 KB

Long-term remission with adalimumab in s

Long-term remission with adalimumab in steroid-dependent Crohn's disease patients with multiple drug intolerances

✍ Fabrizio Bossa; Giuseppe Biscaglia; Antonio Merla; Fulvia Terracciano 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 956 KB

Adalimumab for Crohn's disease in clinic

Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients

✍ Jason M. Swoger; Edward V. Loftus Jr.; William J. Tremaine; William A. Faubion; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Background: We sought to assess the effectiveness and safety of adalimumab for the treatment of Crohn's disease (CD) in clinical practice. Methods: Demographic, clinical, and treatment data were abstracted from the medical record. The primary outcome was clinical response to induction therapy